Insider Transactions Reported by 9 Insiders of Quoin Pharmaceuticals, Ltd.

Symbol
QNRX on Nasdaq
Location
Kfar Saba

Insiders trading volume in the past year

Quoin Pharmaceuticals, Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Myers Chief Executive Officer, Director $271,264 29 May 2025
Denise Carter Chief Operating Officer, Director $271,192 29 May 2025
Dennis Langer Director $128,648 +$128,640 +1608000% 14 Oct 2025
Gordon Dunn Chief Financial Officer $67,985 23 Dec 2024
Anthony James Culverwell Director $45,143 21 Aug 2025
Sally Bridget Lawlor Chief Financial Officer 01 Dec 2025
Natalie Leong Director 21 Aug 2025
Michael Sember Director 29 May 2025
Joseph Cooper Director 29 May 2025

Recent Insider Transactions by Companies or Individuals for Quoin Pharmaceuticals, Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.